Theravance Biopharma, Inc. (TBPH) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Theravance Biopharma, Inc. (TBPH) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $859.4M, listed on NASDAQ, employing roughly 97 people, carrying a beta of 0.19 to the broader market. Theravance Biopharma, Inc. Led by Rick E. Winningham, public since 2014-05-16.
Snapshot as of May 15, 2026.
- Spot Price
- $16.41
- Total OI
- 8.1K